Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-005924
Filing Date
2024-04-26
Accepted
2024-04-26 16:30:29
Documents
23
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240618xdef14a.htm   iXBRL DEF 14A 2195426
2 GRAPHIC tmb-20240618xdef14a001.jpg GRAPHIC 14201
3 GRAPHIC tmb-20240618xdef14a002.jpg GRAPHIC 4301
4 GRAPHIC tmb-20240618xdef14a003.jpg GRAPHIC 6349
5 GRAPHIC tmb-20240618xdef14a004.jpg GRAPHIC 58633
6 GRAPHIC tmb-20240618xdef14a007.jpg GRAPHIC 41462
7 GRAPHIC tmb-20240618xdef14a018.jpg GRAPHIC 58488
8 GRAPHIC tmb-20240618xdef14a019.jpg GRAPHIC 53566
9 GRAPHIC tmb-20240618xdef14a020.jpg GRAPHIC 61727
10 GRAPHIC tmb-20240618xdef14a024.jpg GRAPHIC 5660
  Complete submission text file 0001558370-24-005924.txt   4290546

Data Files

Seq Description Document Type Size
11 EX-101.SCH tmb-20240618.xsd EX-101.SCH 7464
12 EX-101.DEF tmb-20240618_def.xml EX-101.DEF 11861
13 EX-101.LAB tmb-20240618_lab.xml EX-101.LAB 19552
14 EX-101.PRE tmb-20240618_pre.xml EX-101.PRE 9288
26 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240618xdef14a_htm.xml XML 458738
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 24884361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)